EU Must Adopt Innovative Drugs & AI ‘At Scale’ To Plug Cancer Care Gaps

 
• By Eliza Slawther

European countries should establish “implementation budgets” to fund innovative cancer therapies and leverage technologies such as AI in drug R&D to meet the rising demand for cancer care, pharmaceutical industry representatives say.

Immune checkpoint inhibitor
Immune checkpoint inhibitor drugs could improve cancer care in the EU, the EFPIA said • Source: Shutterstock

More from Market Access

More from Pink Sheet